Overview
REM-I platform and Axon Data Suite software for AI-powered, label-free single-cell capture, morphological profiling, and sorting using the Human Foundation Model across oncology, cell therapy, immunology, and ophthalmology research.
Product and company
REM-I platform and Axon Data Suite is a verified product offering linked to the Brel Digital company profile for Deepcell.
Use cases
REM-I platform and Axon Data Suite software for AI-powered, label-free single-cell capture, morphological profiling, and sorting using the Human Foundation Model across oncology, cell therapy, immunology, and ophthalmology research.
Target customer
Pharmaceutical R&D organizations, academic research labs, GxP-regulated facilities, and international institutions with data-sovereignty requirements for single-cell morphology datasets.
Technologies
Primary technologies assigned from the linked company profile: Deep Learning, Healthcare Analytics, Large Language Models, Machine Learning, Predictive Analytics, Vector Database.
Sources and references
- Official product / company source: https://www.deepcell.com/press-releases/deepcell-launches-rem-i-onsite-bringing-fully-on-premises-single-cell-analysis-to-regulated-and-data-sensitive-environments
- Supporting source: https://www.deepcell.com/about/
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- REM-I platform and Axon Data Suite software for AI-powered, label-free single-cell capture, morphological profiling, and sorting using the Human Foundation Model across oncology, cell therapy, immunology, and ophthalmology research.
Extracted from the linked company product description already verified on Brel. No capabilities were invented.